Sustained clinical effectiveness of interferon-β-1b in multiple sclerosis patients

被引：0
|
作者：
Shimpi, AV
Layton, B
Bashir, K
机构：
来源：
ANNALS OF NEUROLOGY | 2004年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [31] The effects of interferon-β1b on expression of CXCR3 on circulating T cells in multiple sclerosis patients
    Nakajima, H.
    Hosokawa, T.
    Sugino, M.
    Kimura, F.
    Hanafusa, T.
    Ikemoto, T.
    Shimizu, A.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 207 - 207
  • [32] RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b
    Iarlori, C
    Reale, M
    Lugaresi, A
    De Luca, G
    Bonanni, L
    Di Iorio, A
    Feliciani, C
    Conti, P
    Gambi, D
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 107 (01) : 100 - 107
  • [33] Interferon-β-1a/interferon-β-1b/methylprednisoloneSystemic sclerosis and Raynaud’s phenomenon: case report
    Reactions Weekly, 2008, 1202 (1) : 21 - 21
  • [34] Interferon-β-1b therapy in multiple sclerosis:: long-term follow-up
    Vermersch, R
    Dufourd-Delalande, S
    Waucquier, N
    Ferriby, D
    Stojkovic, T
    Hautecoeur, R
    de Seze, J
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S246 - S246
  • [35] Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-β-1b: A case report
    Sahraian M.A.
    Moghadasi A.N.
    Owji M.
    Maboudi M.
    Kosari F.
    McGee J.C.
    Minagar A.
    Journal of Medical Case Reports, 7 (1)
  • [36] Axonal metabolic recovery in multiple sclerosis patients treated with interferon β–1b
    Sridar Narayanan
    Nicola De Stefano
    Gordon S. Francis
    Rozie Arnaoutelis
    Zografos Caramanos
    D. Louis Collins
    Daniel Pelletier
    Barry G. W. Arnason
    Jack P. Antel
    Douglas L. Arnold
    Journal of Neurology, 2001, 248 : 979 - 986
  • [37] Response to beta interferon 1b among Saudi patients with multiple sclerosis
    Kargwell, H
    Yaqub, BA
    Al-Deeb, SM
    SAUDI MEDICAL JOURNAL, 2003, 24 (01) : 44 - 48
  • [38] Synergistic immunomodulatory effects of interferon-β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis
    Weber, F
    Polak, T
    Günther, A
    Kubuschok, B
    Janovskaja, J
    Bitsch, A
    Poser, S
    Rieckmann, P
    ANNALS OF NEUROLOGY, 1998, 44 (01) : 27 - 34
  • [39] Axonal metabolic recovery in multiple sclerosis patients treated with interferon β-1b
    Narayanan, S
    De Stefano, N
    Francis, GS
    Arnaoutelis, R
    Caramanos, Z
    Collins, DL
    Pelletier, D
    Arnason, BGW
    Antel, JP
    Arnold, DL
    JOURNAL OF NEUROLOGY, 2001, 248 (11) : 979 - 986
  • [40] Interferon-β-1b treatment efficacy in multiple sclerosis patients in Russia:: 2-year follow-up
    Demina, T
    Khachanova, N
    Davidovskaya, M
    Lash, N
    Popova, N
    Sinbukhova, N
    Gusev, EI
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S246 - S246
12345